SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand

Hospital revenue grew sequentially to $6.8 million; customers purchasing two or more product lines up 14% from the second quarterIn-house production of Neox® and Clarix® on track to begin in the first half of 2027Raises full-year 2026 revenue guidancePOMPANO BEACH, Fla., Nov. 12, 2026 (GLOBE NEWSWI…

BSEM

Related stories